QLGN

8-K - AIxCrypto Holdings, Inc. (0001460702) (Filer)

8-K - AIxCrypto Holdings, Inc. (0001460702) (Filer)

8-K - AIxCrypto Holdings, Inc. (0001460702) (Filer)

SCHEDULE 13D/A - Qualigen Therapeutics, Inc. (0001460702) (Subject)

8-K - Qualigen Therapeutics, Inc. (0001460702) (Filer)

Shareholders approved all proposals, confirming Faraday Future Intelligent Electric Inc. ("Faraday Future") as the Company's new majority and controlling shareholder.Faraday Future will nominate a majority of board seats prior to November 20 as part of the Company's strategic transformation.The Company will host an official renaming and ticker activation ceremony at Nasdaq Headquarters in New York on November 20, adopting the new ticker symbol AIXC.During the ceremony, the Company will unveil a new business model, ecosystem structure, and three-year development roadmap positioning AIxCrypto as a leading gateway to the AI × Web3 era.The transition introduces cross-ecosystem enablement between

10-Q - Qualigen Therapeutics, Inc. (0001460702) (Filer)

SCHEDULE 13G/A - Qualigen Therapeutics, Inc. (0001460702) (Subject)

Dubai, UAE / Beijing, China, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics Inc. (NASDAQ:QLGN) ("Qualigen", "QLGN" or the "Company"), a publicly-traded technology company majority owned by Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("Faraday Future" or "FF"), today announced that it will rebrand as AIxCrypto following its stockholder meeting on November 12, 2025. AIxCrypto's Strategic Roadmap QLGN (soon to be AIxCrypto) has launched its new Web3 and crypto asset business initiatives. Following its targeted rebranding on November 12, the Company will launch the public beta of its BesTrade DeAI Agent by the end of November and release its EAI RWA Utility Token Whitepap

New York, NY, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics Inc. (NASDAQ:QLGN) ("Qualigen", "QLGN" or "Company"), a publicly-trading technology company majority owned by Faraday Future, today announced a strategic partnership with BitGo, the digital asset infrastructure company, to support its C10 treasury strategy, which accumulate and compound a market-cap-weighted basket of the world's top 10 crypto assets (excluding stablecoins). Through this partnership, Qualigen will leverage BitGo's holistic treasury management offering1 that combines access to deep liquidity with secure qualified custody. BitGo's OTC desk will enable Qualigen to efficiently invest across a diversified ba

DEF 14A - Qualigen Therapeutics, Inc. (0001460702) (Filer)

Carlsbad, CA, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) (the "Company") today announced the official launch of C10 Cryptocurrency Asset Treasury (DAT) purchases: Why is this pullback the golden moment CXC10 has been waiting for? The past 48 hours have been brutal for the entire crypto market. Amidst the market's turbulent volatility, approximately $16 billion in leveraged positions were forcibly liquidated, leaving many investors helpless to prevent a significant decline in their paper wealth. In times of widespread panic, we must remain calm. Declines often present opportunities. As Buffett famously said, "When others are greedy, I am fearful; when othe

PRE 14A - Qualigen Therapeutics, Inc. (0001460702) (Filer)

8-K - Qualigen Therapeutics, Inc. (0001460702) (Filer)

8-K - Qualigen Therapeutics, Inc. (0001460702) (Filer)

New York, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of $41 million strategic investment in its client Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen Therapertics"), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer, from its client Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("Faraday Future", "FF" or "Company"), a California-based global shared intelligent electric mobility ecosystem company. The total investment amounts to approximately $41 million

Carlsbad, CA, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or "the Company") today announced the successful closing of a $41 million private investment in public equity (PIPE) financing led by Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("FF"), along with its Founder and Global Co-CEO YT Jia, President Jerry Wang, SIGN Foundation – a blockchain technology company backed by Binance Labs, Sequoia Capital (US, India, China), IDG, and Circle, and other leading investors. FF has invested $30 million in QLGN common and preferred stock, representing approximately 55% of pro forma beneficial ownership. YT Jia, has personally invested approxim

QLGN is expected to rebrand as CXC10 soon, reflecting its new strategic direction around crypto and web3 business. LOS ANGELES, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("Faraday Future", "FF" or "Company"), a California-based global shared intelligent electric mobility ecosystem company, today announced the successful closing of its announced strategic investment in Qualigen Therapeutics, Inc. (NASDAQ:QLGN), a public company establishing new crypto and Web3-related adventures. The total investment amounts to approximately $41 million, led by FF with approximately $30 million, and an additional $4 million invested by FF Founder and Global

8-K - Qualigen Therapeutics, Inc. (0001460702) (Filer)

EFFECT - Qualigen Therapeutics, Inc. (0001460702) (Filer)

8-K - Qualigen Therapeutics, Inc. (0001460702) (Filer)

RW - Qualigen Therapeutics, Inc. (0001460702) (Filer)

Faraday Future is making an investment of approximately $30 million in Qualigen Therapeutics ("QLGN"); FF Founder and Co-CEO YT Jia will invest approximately $4 million (via an FFGP loan) in QLGN with a two-year lockup.The strategic investment, which was announced at the Company's annual 919 event held in Los Angeles on Sept. 19, accelerates the progress of the "Dual-Flywheel & Dual-Bridge" Eco Strategy to maximize stockholder value. QLGN expects to rebrand as CXC10, focusing on three growth engines with six potential major products for crypto/Web3 ecosystem build-ip, targeting to become atop U.S. public company bridging Web2 and Web3, as well as AI and crypto.As of 6 p.m. on September 18, t

LOS ANGELES and CARLSBAD, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("Faraday Future", "FF" or "Company"), a California-based global shared intelligent electric mobility ecosystem company, and Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("QLGN"), jointly announced that they have entered into a securities purchase agreement (the "Agreement") for a private investment in public equity (PIPE) in QLGN's common stock and preferred stock, and will start a crypto and web3-related business. Upon completion of the required stockholder approval process, it is expected that QLGN will rebrand as CXC10, fully focusing on its three growth engines i

LOS ANGELES and CARLSBAD, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("Faraday Future", "FF" or "Company"), a California-based global shared intelligent electric mobility ecosystem company, and Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("QLGN"), jointly announced that they have entered into a securities purchase agreement (the "Agreement") for a private investment in public equity (PIPE) in QLGN's common stock and preferred stock, and will start a in Crypto and web3-related business. The PIPE financing is being led by Faraday Future and its Founder and Global Co-CEO YT Jia, together with other investors including SIGN Foundation, a blockchain